SuperworthNeuroPace profit margin NPCE
Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.
- Net margin, 12 months
- −19.3%
- Operating margin, 12 months
- −15.3%
- Net margin on a year earlier
- +11.3 pts
- Peer median
- 7.8%
Over the twelve months to Jun 30, 2026, NeuroPace kept −19.3% of its revenue as net profit, with an operating margin of −15.3% and a gross margin of 79.6%.
Five years earlier its net margin was −55.0%.
The median for 10 medical instruments and supplies stocks of a similar size is 7.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −22.4% | −18.4% | 78.5% |
| FY2024 | −34.0% | −27.1% | 73.9% |
| FY2023 | −50.4% | −41.5% | 73.6% |
| FY2022 | n/a | −89.6% | 71.4% |
| FY2021 | −79.9% | −52.5% | 74.0% |
| FY2020 | −59.0% | −31.7% | 73.6% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −19.3% | +11.3 pts | −15.3% | |
| Q1 FY26 | −22.6% | +6.8 pts | −19.0% | |
| Q4 FY25 | −22.4% | +11.6 pts | −18.4% | |
| Q3 FY25 | −26.4% | +10.3 pts | −21.6% | |
| Q2 FY25 | −30.7% | +10.9 pts | −25.1% | |
| Q1 FY25 | −29.4% | +16.2 pts | −22.9% | |
| Q4 FY24 | −34.0% | +16.4 pts | −27.1% | |
| Q3 FY24 | −36.7% | +26.2 pts | −30.2% | |
| Q2 FY24 | −41.6% | +35.6 pts | −34.5% | |
| Q1 FY24 | −45.6% | +49.0 pts | −38.2% | |
| Q4 FY23 | −50.4% | n/a | −41.5% | |
| Q3 FY23 | −63.0% | n/a | −53.1% |
Against its peers
Companies in Medical - Instruments & Supplies nearest NeuroPace's size, closest first, today.
| Company | Profit margin |
|---|---|
| NPCENeuroPace | −19.3% |
| EMBCEmbecta | 8.6% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| MOVMovado | 6.0% |
| INFUInfuSystem | 6.0% |
| UTMDUtah Medical Products | 29.0% |
| PDEXPro DEX | 17.6% |
| IRMDIradimed | 26.7% |
| STAAStaar Surgical | 1.1% |
| BVSBioventus | 9.4% |
| Peer median | 7.8% |
Where NeuroPace ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on NeuroPace
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.